Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricPFEPfizerBMYBristol Myers SquibbGSKGSK plc
Snapshot
Price$27.91$62.79$50.82
Market cap$138.61B$118.71B$102.51B
Valuation
P/E21.2x21.5x13.8x
Forward P/E22.3x17x9.8x
Growth
Revenue growth1.4%1.8%4.0%
EPS growth-5.3%26.3%86.7%
Profitability
Net margin11.8%12.3%17.8%
ROE8.4%41.6%35.8%
Balance sheet & cash
Debt / equity0.75x2.44x1.08x
Free cash flow yield11.2%15.4%3.8%
Dividend yield6.6%4.5%3.5%
Verdict
Investment ratingNeutral· 48Favorable· 60Favorable· 66

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearPFEtoday $28BMYtoday $63GSKtoday $51
2027$21.35 – $31.32+12% CAGR$59.46 – $87.21+39% CAGR$71.17 – $104.39+105% CAGR
2028$21.78 – $31.94+7% CAGR$75.08 – $110.12+32% CAGR$132.90 – $194.92+96% CAGR
2029$22.21 – $32.58+5% CAGR$94.81 – $139.05+30% CAGR$248.16 – $363.97+93% CAGR
2030$22.66 – $33.23+4% CAGR$119.72 – $175.58+29% CAGR$463.40 – $679.65+91% CAGR
2031$23.11 – $33.90+4% CAGR$151.17 – $221.71+29% CAGR$865.30 – $1,269.11+90% CAGR
5-yr CAGR-3.7% – 4.0%19.2% – 28.7%76.3% – 90.3%